BCRX: BioCryst Pharmaceuticals Inc
BCRX exchange rate has changed by -0.24% for today. During the day, the instrument was traded at a low of 8.31 and at a high of 8.51.
Follow BioCryst Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BCRX News
- X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval
- BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2025 Earnings Call Transcript
- TD Cowen reiterates BioCryst Pharma stock Buy rating on Orladeyo growth
- BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates
- BioCryst full year 2025 slides: record profit, injectable expansion
- BioCryst earnings beat by $1.08, revenue topped estimates
- Harrow (HROW) Reports Next Week: Wall Street Expects Earnings Growth
- BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy?
- Evercore ISI resumes BioCryst Pharma stock coverage with outperform rating
- Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?
- BioCryst completes $700 million acquisition of Astria Therapeutics
- BioCryst: The $700 Million Pivot From Oral Convenience To Injectable
- BioCryst: A Changed And Interesting Thesis For 2026 (NASDAQ:BCRX)
- BioCryst stock holds steady as Cantor Fitzgerald reaffirms Overweight rating
- Citizens reiterates Market Outperform rating on BioCryst Pharma stock
- 44th Annual J.P. Morgan Healthcare Conference (NASDAQ:BCRX) 2026-01-12
- BioCryst Pharmaceuticals, Inc. (BCRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- BioCryst reports $563 million in ORLADEYO revenue for 2025
Frequently Asked Questions
What is BCRX stock price today?
BioCryst Pharmaceuticals Inc stock is priced at 8.48 today. It trades within 8.31 - 8.51, yesterday's close was 8.50, and trading volume reached 6009. The live price chart of BCRX shows these updates.
Does BioCryst Pharmaceuticals Inc stock pay dividends?
BioCryst Pharmaceuticals Inc is currently valued at 8.48. Dividend policy depends on the company, while investors also watch 13.83% and USD. View the chart live to track BCRX movements.
How to buy BCRX stock?
You can buy BioCryst Pharmaceuticals Inc shares at the current price of 8.48. Orders are usually placed near 8.48 or 8.78, while 6009 and 0.95% show market activity. Follow BCRX updates on the live chart today.
How to invest into BCRX stock?
Investing in BioCryst Pharmaceuticals Inc involves considering the yearly range 6.00 - 11.31 and current price 8.48. Many compare -1.97% and 13.98% before placing orders at 8.48 or 8.78. Explore the BCRX price chart live with daily changes.
What are BioCryst Pharmaceuticals Inc stock highest prices?
The highest price of BioCryst Pharmaceuticals Inc in the past year was 11.31. Within 6.00 - 11.31, the stock fluctuated notably, and comparing with 8.50 helps spot resistance levels. Track BioCryst Pharmaceuticals Inc performance using the live chart.
What are BioCryst Pharmaceuticals Inc stock lowest prices?
The lowest price of BioCryst Pharmaceuticals Inc (BCRX) over the year was 6.00. Comparing it with the current 8.48 and 6.00 - 11.31 shows potential long-term entry points. Watch BCRX moves on the chart live for more details.
When did BCRX stock split?
BioCryst Pharmaceuticals Inc has gone through stock splits historically. These changes are visible in , 8.50, and 13.83% after corporate actions.
- Previous Close
- 8.50
- Open
- 8.40
- Bid
- 8.48
- Ask
- 8.78
- Low
- 8.31
- High
- 8.51
- Volume
- 6.009 K
- Daily Change
- -0.24%
- Month Change
- -1.97%
- 6 Months Change
- 13.98%
- Year Change
- 13.83%